Bioactive Molecules via Morita–Baylis–Hillman Chemistry
Synlett · 23.10.2025 · 36 (17) · 2772-2790
DOI: 10.1055/a-2535-1306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 23.10.2025. Verfasst von Vaidya Rao Jayathirtha und 1 weiteren Autor:innen. Die Arbeit nennt 104 Literaturangaben.
Abstract (Originalsprache)
Morita–Baylis–Hillman (MBH) chemistry was applied to the synthesis of a variety of new chemical entities and their bioactivity was evaluated. Various substances synthesized via MBH chemistry have: antimalarial, anti-inflammatory, antidiabetic, antimicrobial, antitubercular, and anticancer activity and also act as phosphodiesterase inhibitors. There are a few instances animal model and biology studies explored. Several hits and lead molecules are identified and their IC50 values listed. The simplicity of Morita–Baylis–Hillman chemistry provides a realistic, impactful option for the pharma industry. 1 Introduction 2 Antimalarial Activity 3 Anti-inflammatory Activity of MBH Adducts Coupled to Heterocycles 4 Antidiabetic Activity of Epalrestat Analogues Derived from MBH Adducts 5 Antimicrobial Activity 6 Antitubercular Activity of N-Cinnamyl-isatins 7 Inhibitors of Phosphodiesterase-3 (PDE3); Cardiotonic Agents 8 Anticancer Activity 9 Asymmetric Morita–Baylis–Hillman Reactions 10 Conclusion
Zitieren
APA
Jayathirtha, V. R., & Kumar, C. N. S. S. P. (2025). Bioactive Molecules via Morita–Baylis–Hillman Chemistry. Synlett, 36(17), 2772-2790. https://doi.org/10.1055/a-2535-1306
Vancouver
Jayathirtha VR, Kumar CNSSP. Bioactive Molecules via Morita–Baylis–Hillman Chemistry. Synlett. 2025;36(17):2772-2790. doi:10.1055/a-2535-1306
BibTeX
@article{Jayathirtha2025,
author = {Jayathirtha, Vaidya Rao and Kumar, Ch. N. S. Sai Pavan},
title = {Bioactive Molecules via Morita–Baylis–Hillman Chemistry},
journal = {Synlett},
year = {2025},
volume = {36},
number = {17},
pages = {2772--2790},
doi = {10.1055/a-2535-1306}
}
EUVIMED